DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

Similar documents
DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS)

Walsall CCG Supported Blood Glucose Meters April 2018

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

Type 2 Diabetes Recommended SMBG

Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes

DATE RECEIVED 09/10/2017 SUBJECT Formulary PASSED TO Mary DATE PASSED 09/10/2017 RESPOND BY 27/10/2017 CATEGORY Business FoI NUMBER

Guidance for the choice of blood glucose testing meters, strips and lancets

NHS Greater Glasgow and Clyde Adult Blood Glucose Meter and Test Strip Formulary

Blood Glucose Test Strip Guidelines

NHS Greater Glasgow and Clyde Adult Blood Glucose and Combined Ketone Meter and Test Strip Formulary

GUIDELINE FOR SELF MONITORING OF BLOOD GLUCOSE IN ADULTS WITH DIABETES

THE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.

Guideline on the Choice of Blood Glucose Meters, Ketone Meters and Test Strips for children and young people with. TYPE 1 DIABETES (November 2018)

medicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre.

Monitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse

Commissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018

Guideline on the Choice of Glucometers and Ketometers for ADULTS with TYPE 1 DIABETES (December 2018)

Commissioning Statement

FreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ

Placename CCG. Policies for the Commissioning of Healthcare

How to Access A Free Blood Glucose Meter

HYDROXYBUTERATE) Gluco Rx Evolve KetoneTest Strips

CHEMICAL REAGENTS 478 PART 9 CHEMICAL REAGENTS. This document is dated 1 st July 2015.

CHEMICAL REAGENTS 478 PART 9 CHEMICAL REAGENTS. This document is dated 1 st March 2016.

Implementation of Freestyle Libre prescribing guidance across the NHS in London

CHEMICAL REAGENTS 478 CHEMICAL REAGENTS. This document is dated 1 st March 2018

Home Monitoring Diary

Approval of Multiple Diabetes Management Products and Mesalazine proposals

Essential advice for people with diabetes from Accu-Chek. Time to test. G1812 Time to Test leaflet v5.indd 1 25/02/ :43

Flash Glucose Monitoring (Flash GM) Frequently asked questions (November 2018)

CHEMICAL REAGENTS 478 CHEMICAL REAGENTS. This document is dated 1 st October 2017

NICE to. know... The facts you need to make the most of your diabetes care.

Information leaflet for MDI patients. Improving Diabetes using Diasend

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

Time to test. Do you do it enough? Essential advice for people with diabetes from Accu-Chek

Diabetes Newly Diagnosed with NO evidence of DKA

NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system

Placename CCG. Policies for the Commissioning of Healthcare

5.2 mmol USER GUIDE 5.2. Uses only CONTOUR NEXT blood glucose test strips from Bayer. Wireless Blood Glucose Monitoring System 12:00 PM METER BG

PROCEDURE FOR BLOOD GLUCOSE MONITORING

NHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Goulburn Region Preschool Association Inc.

Description of the technology

Quick Reference Guide

Quick Reference Guide

Glucometers Gastrostomy Tubes Nasogastric Tubes Insulin pumps Continuous Glucose monitoring system Closed Loop Smart phones/tablets

5.2 mmol USER GUIDE. 5.2 mmol/l. Bolus Reminder Notes. 12:00 PM l 10/13. Uses only Contour Next blood glucose test strips.

Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus

Quick Reference Guide

Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age)

Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus

Summary of Significant Changes at this Revision. Items Required

Blood glucose test strips (BGTS) evaluation protocol and results. Update April Version 4.1. Note:

Guidelines for managing the health care needs of children and young persons with diabetes in education

Plug-and-play goes online

In keeping with the Scottish Diabetes Group criteria, use should be restricted to those who:

CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY

Software Version 2.0. User s Guide

5.2mmol/L. 5.2 mmol USER GUIDE. Uses only CONTOUR NEXT blood glucose test strips from Bayer. Wireless Blood Glucose Monitoring System

UNCOVERING THE BENEFITS OF THE ACCU- CHEK BOLUS ADVISOR MICHAEL PORTER CDE

QOF Indicator DM013:

North West London Diabetes Guidelines Helping healthcare practitioners manage adults with diabetes

Diabetes Subcommittee of PTAC meeting held 3 March (minutes for web publishing)

Blood Glucose monitoring during extra-corporeal renal therapy and plasmapheresis.

BLOOD GLUCOSE METERS ACCURACY REQUIREMENTS

Urgent field safety notice

Diabetes Management App. Instruction Manual

University College Hospital. Blood glucose and HbA 1 c targets

FreeStyle Optium Neo H. Product Training. Blood Glucose and Ketone Monitoring System. Healthcare professional portrayal.

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019

Title Management of Children and Young People with Newly Diagnosed Type 1 Diabetes Mellitus Guideline

IMPORTANT SAFETY INFORMATION

Home Glucose Monitoring

BLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA

Blood glucose monitoring and compatibility equipment checker

Urgent field safety notice

DIABETES: SAFE DRIVING AND THE DVLA

Title: Abbott Optium Xceed Glucose Meter Effective date: 16/05/2011. Summary of Significant Changes at this Revision. SOP updated.

Page 1 of 7 ADDENDUM NO. 2. September 19, Provision of Blood Glucose Monitors and Consumables RFP # H General

Continuous Subcutaneous Insulin Infusion (CSII) pump therapy

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

The performance of Microdot Test Strips has been evaluated both in laboratory and in clinical tests.

requesting information regarding prescribing incentive schemes in Canterbury and Coastal Clinical Commissioning Group

TRAVEL & TYPE 1 DIABETES ndss.com.au

User s Manual Blood Glucose Meter

This Diabetes Policy should be read in conjunction with the Dealing with Medical Conditions Policy of Auburn South Preschool.

DIABETES POLICY. Mandatory Quality Area 2

For more comprehensive information, please refer to the t:connect Application User Guide available online at: Getting Started Guide.

Diabetes is a lifelong, chronic. Survey on the quality of diabetes care in prison settings across the UK. Keith Booles

Policy for Supporting. Children and Young People with. Diabetes in Education

Your pet s diabetes is manageable

Accuracy and Usability Evaluation of Six Commercially Available Blood Glucose Monitoring Systems

Commissioning Policy Individual Funding Request

Transcription:

DIABETES BLOOD GLUCOSE MONITORING AT HOME (ADULTS) Type 2 Diabetes Clinical Guideline Self-monitoring of blood glucose (SMBG) should be considered but not routinely offered for adults with type 2 diabetes unless: The person is on insulin or There is evidence of hypoglycaemic episodes or The person is on oral medication that may increase their risk of hypoglycaemia or The person is pregnant, or is planning to become pregnant. The DVLA At a glance guide to the current medical standards of fitness to drive should be taken into account when offering SMBG for adults with type 2 diabetes. The following criteria should be followed for patients with type 2 diabetes: 1 SMBG should be considered for appropriate newly diagnosed patients as some may need to monitor frequently initially in order to provide them with information in relation to their activities and the effect of dietary measures and treatment prescribed. The need for continued SMBG should be reviewed regularly. 2 Patients taking sulfonylureas, or other agents that may increase the risk of hypoglycaemia should have their monitoring frequency discussed with the clinician. Testing frequency should be determined on an individual patient basis. This applies particularly to patients on longer acting agents. 3 Patients should monitor their blood glucose levels more frequently in the following circumstances: Inter-current illnesses Change in oral hypoglycaemic treatment Exercise Carbohydrate counting If there are difficulties in venesection or if glycosylated haemoglobin is unreliable*. 4 Consider short term SMBG in adults with type 2 diabetes (and review treatment as necessary): When starting treatment with oral or IV corticosteroids or To confirm suspected hypoglycaemia. *Glycosylated haemoglobin may be unreliable in the following situations: (i) Patients with anaemia; (ii) Patients with polycythaemia; (iii) Patients with haemoglobinopathies; (iv) Patients in whom venesection is not possible

If adults with type 2 diabetes are self-monitoring their blood glucose levels, then a structured assessment needs to be undertaken at least annually. The assessment should include: The person s self-monitoring skills The quality and frequency of testing Checking the person knows how to interpret the blood glucose results and what action to take The impact on the person s quality of life The continued benefit to the person The equipment used. Type 1 Diabetes (and type 2 diabetes using insulin therapy) Recommend SMBG for all adults with type 1 diabetes. For patients who are stable, blood glucose should be tested at least four times a day (pre-meals and pre-bed) on two days per week. Patients may need to adapt the frequency of their blood glucose testing due to numerous factors and should be supported to test at least 4 times a day, and up to 10 times a day if any of the following apply: 1. Desired target HbA1c level is not achieved. 2. Frequency of hypoglycaemic episodes increases 3. There is a legal requirement to do so (such as in line with DVLA guidance) 4. Inter-current illnesses 2. Carbohydrate counting 3. Pregnancy (including planning pregnancy, during pregnancy and while breastfeeding) 4. Before and during driving 5. Before during and after exercise 6. Those using insulin pumps. 7. If there is a need to know blood glucose levels >4 times a day for other reasons (e.g. impaired awareness of hypoglycaemia, high risk activities) Consider ketone monitoring as part of sick day rules for adults with type 1 diabetes, to facilitate self-management of an episode of hyperglycaemia. Access to testing strips MUST NOT be restricted for patients using insulin or for paediatric patients (who are excluded from this guideline)

DVLA Guidance When reviewing SMBG please be aware of the DVLA At a glance guide to the current medical standards of fitness to drive. All detail regarding any legal requirements can be found on the DVLA website. Blood Glucose Meter Expenditure A wide variety of blood glucose meters are currently available with test strips ranging in price from less than 10 up to 15 per pack of 50. The aim is to move to a position where 80% of prescriptions are for the lower cost test strips, thus reserving more specialist meters for those situations in which they are clearly clinically indicated. ISO Quality Standards ISO (International Organisation for Standardisation) 15197:2013 (E) describes the requirements for blood glucose monitoring systems using capillary blood (ISO, 2013). All capillary blood glucose monitoring strips must meet the ISO standards by 2016. The standards cover the following areas: Ease of operation, maintenance, cleaning. Ensuring the visual display is clear and there is no likelihood of misinterpretation of the result. Safety and reliability (e.g. no risk of electric shocks to the user, resistance to shock, vibration and heat). Precision, accuracy and influence by abnormalities in haematocrit and other interferences. User performance evaluation, including ease of understanding instructions. All meters featured on these guidelines comply with the ISO standards 2013 (independent or manufacturer s data). Selection Criteria The low cost blood glucose meters were evaluated by the Diabetic Specialist Nurses at Wirral University Teaching Hospital (WUTH). The guidelines were consulted on by Medicines Management QIPP, GPs through Prescribing Group Meetings, Practice Nurses, Diabetes QIPP and WUTH pharmacy. The lists below are not exhaustive as other meters which use low cost (< 10 per 50) strips are available (see Drug Tariff or BNF), however Practice Nurses should familiarise themselves with a selection of meters (that are ISO compliant) and make them available for demonstration and supply to patients. Patients who have been provided with one of the meters listed (or another meter using low cost strips) who subsequently choose to purchase or request a different meter in excess of their individual clinical need, should be advised that the CCG does not support provision of higher cost

test strips (in these instances). Expiry dates of test strips The minimum expiry date for these lower cost blood glucose test strips is three months from the time the pot of test strips is opened. For those testing on average of twice a day this means that the supply of test strips will be exhausted before the three month period is over. For those that test infrequently (for example once or twice a week) then test strips with an expiry date of at least six months from the time the pot is opened might be a more cost effective option. To extend the expiry date of useable strips, a number of manufacturers have divided their strips in smaller pack sizes (e.g. 2 x 25 strips). Therefore if the pots of strips are opened consecutively this extends the total time the supply of 50 strips can be used. For example, 2 x 25 strips with an expiry date of 3 months at the time of opening if used consecutively can last in total a maximum of 6 months.

Recommendations 80% of diabetic patients should use low cost blood glucose meters. The formulary choices for low cost meters are listed below: Meter Name Accu-chek Active Accu-chek Performa Nano Glucomen Areo GlucoRx Nexus GlucoRx Nexus Mini Testing Strips Range and Test Time Shelf life once opened Special features Active testing strips 9.95/ 50 0.6-33.3mmol/l 5 seconds Accu-chek Performa 9.95/50 0.6-33.3mmol/l 5 seconds Glucomen Areo sensor 9.95/50 1.1-33.3mmol/l 5 seconds GlucoRx Nexus 9.95 / 50 1.1-33.3mmol/l 5 seconds Date on container Date on container 12 months 6 months (but comes as 2x25 strips) Strip date expiry warning Hypoglycaemia indicator Glow in the dark Display. NB First line for existing or gestational diabetes during pregnancy Memory 500 500 730 1000 Compatible Lancets and Lancing Device Company / Customer Care Line Quality Control solution shelf life once open Accu-Chek softclix finger pricker with softclix lancet Roche Careline 0800 701 000 Accu-Chek fastclix finger pricker Roche Careline 0800 701 000 Glucoject dual plus device and lancets Glucomen 0800 243667 Ketone warning GlucoRx Lancing Device and Lancets Dime 01483 755 133 3 months 3 months 3 months 3 months Consumables (e.g. batteries, Quality Control solution, USB cables etc.) are available free of charge from the Company Customer Care lines. Software download is Available for all listed meters. When changing a patient s meter, please help reduce waste where possible by ensuring test strips for the previous meter are used before ordering the new strips.

The following patient groups may be less suitable for a low cost meter. However, consideration must be given to trying a low cost meter first line, before using the meters below. It is expected that only 20% of diabetic patients would be suitable for a higher cost meter/strips. Patient group Children/adolescents aged less than 18 years Those with existing or gestational diabetes during pregnancy who are unable to use first choice meter (Glucomen Areo) Those using insulin pumps or carbohydrate counting Those patients who need to test their blood glucose as they hold a group 2 driving licence Reason for exclusion or special consideration Meter choice should be agreed on an individual patient basis with the paediatric specialist nurse. These patients are excluded from this guideline. If the first line meter (Glucomen Areo) is unable to be used then the Contour Next meter is a second choice. This is for exceptional cases only. May be using specific meters that provide dosing advice on insulin requirements. For Bolus Advisor Systems, Insulin Calculators and/or Carbohydrate Counting. The Aviva strip is used for the Accu-Chek Aviva Expert System or the FreeStyle Lite test strip used for the FreeStyle InsuLinx. Meters with a sufficient memory are required. However, these can include the lower cost meters, as detailed in the table above and consideration should be given to using these first. Those patients, mainly type 1 diabetics, who need the facility to test for ketones Those who are registered blind or partially sighted Those on insulin that require discreet testing and /or those that have problems with manual dexterity. Those patients on insulin who require support to encourage adherence with suggested monitoring regimen. The recommended meters are the Glucomen Areo 2K (Glucomen Areo sensors with Glucomen Areo β Ketone sensors) and the FreeStyle Optium Neo (FreeStyle Optium with FreeStyle Optium β Ketone test strips). NB: Glucomen Areo 2K is the most cost effective for both blood glucose and ketone testing. The FreeStyle Optium Neo should only be used when a patient is unable to use the Glucomen Areo 2K. Will use meters with large displays or with voice guidance. The recommended meter is GlucoRx Nexus Voice meter. The Accu-chek Mobile can be used for those patients that need to test discreetly, have problems with their manual dexterity or need support to encourage compliance with suggested monitoring regimen. This meter is only intended for insulin patients. Any patient for whom the GP or specialist considers it appropriate that Meter expected to be chosen from the following formulary choices, in the they remain on a specific meter table below.

The formulary choices for the 20% of patients that are not recommended to use the first line meters are listed below. Please note green colour coding are preferred second line choices (where appropriate): Meter Name Accu-chek Mobile Glucomen Areo 2K GlucoRx Voice meter Accu-chek Aviva Expert Contour Next FreeStyle Optium Neo FreeStyle InsuLinx Testing Strips Range and Test Time Accu-chek Mobile 9.99/50 Please note that this is the most cost effective second line meter (also no sharps bin required). 0.6-33.3 mmol/l 5 seconds Glucomen Areo 9.95/50 Glucomen Areo β ketone 9.95/10 First line Glucose/Ketone meter. 1.1-33.3 mmol/l 5 seconds GlucoRx Nexus 9.95/50 1.1-33.3mmol/l 7 seconds Accu-chek Aviva 16.09/50 0.6-33.3 mmol/l 5 seconds Contour Next 15.04/50 Intended for use as second line for existing or gestational diabetes during pregnancy, only in exceptional circumstances. 0.6-33.3 mmol/l 5 seconds FreeStyle Optium 16.00/50 FreeStyle Optium β Ketone 21.53/10 Intended for use as second line, only in exceptional circumstances. Optium strips: 1.1-27.8 mmol/l 5 secs FreeStyle Lite 16.10/50 1.1-27.8mml/l 5 secs Shelf life once opened Special features 90 days Ketones: Until printed expiry date as individually wrapped Glucose: 12 months 50 continuous strips and 6 lancets in a drum so no single lancets to touch. No clinical waste. Blood glucose testing with the added function of ketone testing Memory 2000 730 glucose 100 - ketones 6 months (but comes as 2x25 strips) Small and portable device Until printed expiry date even if pot opened To provide dosing advice on insulin requirements Until printed expiry date even if pot opened No coding, quality test control sensitive Ketones: Until printed expiry date as individually wrapped Blood glucose testing with the added function of ketone testing Until printed expiry date even if pot opened Bolus Adviser System 450 1000 480 450 Up to 165 days

Compatible Lancets and Lancing Device Company/Customer Care Line Quality Control solution shelf life once opened Accu-Chek FastClix finger pricker. All in one system Roche Diagnostics 0800 701 000 Glucoject dual plus device and lancets Glucomen 0800 243667 GlucoRx Lancing Device and Lancets Dime 01483 755 133 Accu-chek FastClix Finger Pricker and FastClix Lancet Drum Roche Diagnostics 0800 701 000 Microlet 2 Device and Microlet Lancets Ascensia Diabetes Care 0345 600 6030 Easy Touch Lancing Device and Lancets Abbott Diabetes Care 0500 467 466 Single use 3 months 3 months 3 months 6 months 90 days 90 days Easy Touch Lancing Device and Lancets Abbott Diabetes Care 0500 467 466 Consumables (e.g. batteries, Quality Control solution, USB cables etc.) are available free of charge from the Company Customer Care lines. Software download is available for all the meters listed. When changing a patient s meter please help reduce waste where possible by ensuring test strips for the previous meter are used before ordering the new strips. Cost Effective Lancets there are a range of lancets available at varying prices (please see BNF/Drug Tariff). A recommended cost effective lancet is the GlucoRx Lancets, which cost 5.50 per 200. These fit most lancing devices, but do not fit any Roche products. GlucoRx will provide their lancing device free of charge to practices if they wish to prescribe the GlucoRx Lancets. Prices correct as of October 2017 (Drug Tariff October 2017)